
Cooper Companies (COO) | News Based Sentiment Analysis
TL;DR: Cooper Companies News Sentiment Overview
Last Updated: Oct 03, 2025 (UTC)News based Sentiment: MIXED | Importance Score: 7
Key Insights
Latest News Analysis: Cooper Companies
Last Updated: Oct 03, 2025 (UTC)Cooper Companies: Mixed Signals in October
Detailed Analysis
- On October 1, 2025, Goldman Sachs initiated a "Sell" rating on The Cooper Companies (COO), citing concerns about valuation at $13.6 billion (P/E ratio of 33.6x) and anticipating a slower recovery than the market expects. This suggests potential downside risk for investors, particularly given the firm's $64.00 price target implying approximately 7% downside.
- Analyst sentiment appears mixed, with several firms lowering their price targets on October 1, 2025. The average 12-month price target decreased by 15.77% to $78.7 from a previous average of $93.44, indicating growing caution among analysts regarding the stock's near-term prospects.
- Despite the analyst concerns, insiders demonstrated confidence in the company, purchasing 17,975 shares worth $1,216,346 over the past 90 days, including a purchase by COO Gerard H. Warner III of 1,450 shares at $69.23/share ($100,383.50) on October 3, 2025. This insider activity is coupled with a significant $2.0 billion stock repurchase program, representing 15.4% of outstanding shares, authorized by the Board on October 3, 2025.
- Cooper Companies reported Q3 2025 EPS of $1.10, exceeding estimates of $1.07 by $0.03, and revenue of $1.06 billion, meeting consensus expectations, representing a 5.7% year-over-year increase on October 3, 2025. This positive earnings surprise was accompanied by a net margin of 10.08% and ROE of 9.82%.
- Looking ahead, Cooper Companies provided FY 2025 EPS guidance of $4.080-$4.120, slightly above the $3.98 analyst expectation, but revised down its organic growth guidance due to Q3 results not meeting expectations, as reported on October 3, 2025. Simply Wall St projects $4.9 billion revenue and $786.2 million earnings by 2028, requiring 6.4% yearly revenue growth.
- Institutional investors have been increasing their stakes in Cooper Companies, with Lbp Am Sa increasing its position by 79.2% to 125,325 shares valued at $8.9 million as of October 2, 2025. Total shares owned by institutions increased by 3.94% to 245,989K shares, suggesting continued institutional support despite recent analyst downgrades.
The Investment Story: October proved to be a month of mixed signals for Cooper Companies, with a negative analyst initiation from Goldman Sachs countered by a positive earnings surprise and significant insider buying, alongside a substantial stock repurchase program. The company is navigating a challenging growth environment, as evidenced by revised guidance.
What It Means for Investors: Investors face a complex picture. While the earnings beat and insider activity are encouraging, the "Sell" rating and lowered price targets suggest caution. The stock repurchase program provides some support, but the slower growth outlook warrants careful consideration. Valuation remains a key concern.
Looking Ahead: Investors should closely monitor the rollout of the MyDAY product and the resolution of manufacturing constraints, as well as track the impact of the revised organic growth guidance on future earnings. Further analyst revisions and institutional activity will also be important indicators.
The Bottom Line: October's developments highlight a period of transition for Cooper Companies. While short-term performance appears solid, longer-term growth prospects are uncertain, making this a stock that requires careful monitoring and a reassessment of risk tolerance.
Cooper Companies Competitors News Sentiment Analysis
Compare news sentiment across the main stock and its key competitors based on recent market analysis.
Company | Sentiment | Recent Headline | Importance |
---|---|---|---|
![]()
Cooper Companies Main
coo | nasdaq | mixed | Cooper Companies: Mixed Signals in October |
7
/10 |
![]()
ISRG | NASDAQ | positive | Intuitive Surgical: Strong Q2 & Innovation Drive Optimism |
7
/10 |
![]()
BDX | NYSE | positive | BDX: Strong Earnings & Automation Push Drive October Gains |
7
/10 |
A
ALC | NYSE | mixed | Alcon: Earnings Beat, Acquisition & Mixed Signals |
7
/10 |
![]()
RMD | NYSE | mixed | ResMed: Insider Moves & Trade Probe - October Update |
7
/10 |
![]()
WST | NYSE | positive | West Pharma: Strong Q2 & Rising Targets, But Valuation Looms |
7
/10 |
Note: Sentiment analysis is based on the most recent monthly news data. Importance scores range from 1-10, with higher scores indicating greater market relevance.
Important: News sentiment data is updated regularly and based on publicly available news sources. Sentiment scores and analysis represent algorithmic assessments of market sentiment. This information is for educational purposes only and should not be considered as investment advice. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.